Navigation Links
NCD - 30 Years of Disability Policy Leadership - 1978 - 2008
Date:5/8/2008

National Council on Disability Monthly Bulletin for April, 2008

WASHINGTON, May 8 /PRNewswire-USNewswire/ -- Following is the National Council on Disability's monthly bulletin for April, 2008:

The Bulletin, which is free of charge and available at NCD's award-winning Web site (http://www.ncd.gov), brings you the latest issues and news affecting people with disabilities. To subscribe to the NCD listserv, go to http://listserv.access.gpo.gov, click on Online mailing list archives, select NCD-NEWS-L, click on Join or leave the list, then complete the short subscription form. Please send your editorial comments to Bulletin editor Mark S. Quigley (mquigley@ncd.gov).

NCD Conducts Quarterly Meeting

NCD conducted its quarterly meeting April 21-23 at the Westin Arlington Gateway in Arlington, VA.

During the meeting, NCD heard presentations on emergency preparedness and other issues of importance to people with disabilities. Seventy-four people participated in the meeting and another 45 people attended the NCD-sponsored reception.

Under the Homeland Security Appropriations Bill (H.R. 5441), signed by President Bush on October 4, 2006, NCD was assigned key responsibilities for disability-related issues in homeland security, so much of the agenda focused on related subjects.

On April 22, Curt Decker, executive director, National Disability Rights Network, discussed emergency preparedness and lessons learned, as well as their impact on organizations, and inclusion of the disability community in current preparedness activities. That same day, the following presenters discussed the federal role in emergency preparedness: Nicole Francis, counsel, House Committee on Homeland Security; Andy Weis, general counsel, Office of Senator Susan M. Collins, Senate Committee on Homeland Security; Scott Spicer, senior ana
'/>"/>

SOURCE National Council on Disability
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. US Female Sterilization Market to Grow to Almost $245 Million Over the Next Five Years
2. Medicare costs estimated to top $21.1 billion for 5 years of care for elderly cancer patients
3. New National Survey: 84% of Americans Over 50 Expect a Family Member to Move into an Assisted Living Community Within the Next 10 Years
4. Emerging Ultrasound Market to Grow Rapidly Over Next Five Years
5. ANTHELIOS 40 Sunscreen with Mexoryl(TM) SX From the brand trusted for over 15 years worldwide to offer high UVA protection
6. Current Flu Season Worst in 4 Years
7. Entertainment Industry Foundation Revlon Run/Walk for Women Celebrates 11 Years in New York City on Saturday, May 3
8. Breakaway Technologies Celebrates 10 Years in Business
9. WOCN: Around the World in 40 Years
10. Inactive kids face 6-fold risk of heart disease by teen years, study finds
11. Owner of Medicare Billing Service Sentenced to 10 Years In Prison For Role in $170 Million Medicare Fraud Scheme
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... essential fatty acids commonly found in fatty fish ... to research published by the American Psychological Association. ... problems found in people with schizophrenia; bipolar, obsessive-compulsive, ... afflictions of the nervous system. , The ... , provides more evidence that fish is brain ...
(Date:12/16/2009)... cut bleeding time in half, but use in humans is ... Hoping to improve on nature, researchers have built and tested ... used in trauma or other cases where blood just won,t ... material that is used in degradable stitches, which dissolve in ... engineering at Case Western Reserve University, and lead author of ...
(Date:12/16/2009)... Neurological Stress Reduction Therapy or NSRTSM is found very effective ... such as allergies, asthma, migraines, chronic fatigue and a wide ... the country are using this holistic therapy including over 50 ... ... Minneapolis, MN (Vocus) December 14, 2009 -- BioVeda ...
(Date:12/16/2009)... government report finds , , WEDNESDAY, Dec. 16 (HealthDay News) ... 45.4 million Americans of all ages -- or 15.1 ... according to new National Health Interview Survey statistics released ... of all ages had been uninsured for at least ... 31.9 million (10.6 percent) had been uninsured for more ...
(Date:12/16/2009)... Dec. 16 OrthoAccel Technologies, Inc., developers ... an acceleration device to enhance orthodontics, announced Alison ... the UK. Ms. Davies has spent the ... the dental industry, most recently for nine years ... , makers of Invisalign . ...
Breaking Medicine News(10 mins):Health News:New study links DHA type of omega-3 to better nervous-system function 2Health News:Synthetic Platelets Put the Brakes on Blood Loss 2Health News:Synthetic Platelets Put the Brakes on Blood Loss 3Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 2Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 3Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 4Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 5Health News:Over 45 Million Americans Now Lack Health Insurance 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 3Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 4
... Accelerate Manufacture of Clinical Trial ... Pharmaceuticals, ... Michigan company specializing in winning FDA approval,for new drugs and medical ... award. RAA received the award for its development,of a fast-track process ...
... NATICK, Mass., Oct. 17 Boston Scientific,Corporation ... initiatives designed to,enhance short- and long-term shareholder value, ... as well as substantial expense and head,count reductions ... The,Company also said it is making good progress ...
... Oct. 17 GenPrime, Inc. a leading,provider of ... of its Bacterial Contamination Test for Platelets(TM). The,test ... presence of aerobic and,anaerobic bacteria commonly found in ... a 510 (K) pre-market notification with the Food,and ...
... ,Haemonetics Corporation (NYSE: HAE ) is pleased ... effective October 22, 2007 as President,Haemonetics Japan. Ms. ... who previously announced plans to retire. Brian ... tremendous experience and a proven track record for ...
... Address FDA,s Next Big Challenge, WASHINGTON, Oct. 17 ... information on drugs,and devices to physicians and the public?, ... will discuss and debate at a,landmark Colloquium, Communicating Risk/Safety ... Food and Drug Law Institute (FDLI),Dec. 6, 2007, in ...
... Kyphon Inc.,(Nasdaq: KYPH ) today announced ... and the Foundation for Osteoporosis Research,and Education (FORE) ... during World Osteoporosis Day on Saturday, October 20, ... go to: http://www.prnewswire.com/mnr/kyphon/29938/ To ...
Other Medicine News:Health News:Regulatory Affairs Associates Gets New Drugs Tested Faster, Wins 2007 Innovation Michigan Award 2Health News:Boston Scientific Announces New Initiatives to Increase Shareholder Value 2Health News:Boston Scientific Announces New Initiatives to Increase Shareholder Value 3Health News:Boston Scientific Announces New Initiatives to Increase Shareholder Value 4Health News:Boston Scientific Announces New Initiatives to Increase Shareholder Value 5Health News:GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets 2Health News:Keiko Hattori Joins Haemonetics as President of Haemonetics Japan 2Health News:Food and Drug Law Institute Sponsors Colloquium on Communicating Risk/Safety Drug Information 2Health News:Video: Kyphon Supports World Osteoporosis Day on October 20, 2007 to Raise Awareness of Osteoporosis and Spinal Fracture Risk 2Health News:Video: Kyphon Supports World Osteoporosis Day on October 20, 2007 to Raise Awareness of Osteoporosis and Spinal Fracture Risk 3
(Date:12/16/2009)... ALTO, Calif., Dec. 16 The Boards ... Corporation are delighted to announce the merger of ... the field of RNAi (RNA interference). The ... have multiple RNAi discovery, development and delivery technologies, ... a broad portfolio of intellectual property. ,, ...
(Date:12/16/2009)... 16 ChemoCentryx, Inc. today announced that ... 2 clinical trial of CCX354, an orally-bioavailable, novel, ... CCR1 chemokine receptor for the treatment of rheumatoid ... potent and selective antagonist of CCR1, a chemokine ... such as monocytes and macrophages, associated with the ...
(Date:12/15/2009)... ARDEE, Ireland, Dec. 15 Warner Chilcott ... its subsidiary Warner Chilcott Corporation (the "Company") has ... and subject to the conditions set forth in ... Statement dated December 15, 2009 (the "Offer to ... 8.75% senior subordinated notes due 2015 (the "Notes"). ...
Breaking Medicine Technology:Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 2Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 3Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 4Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 5Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 6ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 2ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 3ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 4ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 5Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 2Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 3Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 4Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 5Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 6Paul Marks prize recognizes 3 young cancer researchers 58437 1Paul Marks prize recognizes 3 young cancer researchers 58437 2Paul Marks prize recognizes 3 young cancer researchers 58437 3Paul Marks prize recognizes 3 young cancer researchers 58437 4Paul Marks prize recognizes 3 young cancer researchers 58437 5Women who make poor shoe choices at risk for foot pain later in life 58432 1Women who make poor shoe choices at risk for foot pain later in life 58432 2Katrina Hero Lt General Russel Honor 28Ret 29 to Speak on H1N1 Flu Preparedness at Press Briefing Following AmeriHealth Mercy PerformRx Conferenc 58430 1Katrina Hero Lt General Russel Honor 28Ret 29 to Speak on H1N1 Flu Preparedness at Press Briefing Following AmeriHealth Mercy PerformRx Conferenc 58430 2
... Unique monoclonal antibody successfully targets human leukemic stem ... Australia,s leading,biopharmaceutical company, has today presented data at ... which demonstrate the promising,pre-clinical activity of a novel ... leukemia (AML)., AML is an aggressive cancer ...
... Presentations Detail Progress with VeraTag(TM) Assays in Breast ... ... MGRM ) today announced five posters to be,presented at the 30th San ... 16, 2007. Following are details for,each embargoed session:, -- Friday, December ...
Other Medicine Technology:Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML) 2Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML) 3Monogram Announces Posters to be Presented at the 30th San Antonio Breast Cancer Symposium 2Monogram Announces Posters to be Presented at the 30th San Antonio Breast Cancer Symposium 3
Enzyme Immunoassay for the Quantitative Measurement of Ovarian Cancer Antigen CA-125 in Human Serum...
Abbott offers an array of both in-vitro and molecular diagnostic tests for the detection and monitoring of cancerous conditions in patients....
... BrainSUITE iMRI is a neurosurgical OR ... and diagnostic tools, including iMRI, necessary ... BrainSUITE iMRI, neurosurgical treatments are performed ... and designed for MR compatibility and ...
... Quality EEG recording is assured even ... Neurofax has high performance, high sensitivity ... ECG rejection filter, shielded electrodes and a ... connection. Neurofax is a complete and ...
Medicine Products: